|
|
|
|
pmid:
|
Dubé MP et al. |
Successful short-term suppression of clarithromycin-resistant Mycobacterium avium complex bacteremia in AIDS. California Collaborative Treatment Group. |
1999 |
Clin. Infect. Dis. |
pmid:10028084
|
Goh KL et al. |
Optimal treatment for duodenal ulcer disease: a cost-decision analysis in Malaysian patients. |
1999 |
J. Gastroenterol. Hepatol. |
pmid:10029275
|
Horgen L et al. |
Postantibiotic effects of rifampin, amikacin, clarithromycin and ethambutol used alone or in various two-, three- and four-drug combinations against Mycobacterium avium. |
1999 |
FEMS Immunol. Med. Microbiol. |
pmid:10030545
|
Sakurai K et al. |
[Importance of drug selection and the use of sensitivity tests for the eradication therapy for Helicobacter pylori]. |
1999 |
Nippon Rinsho |
pmid:10036938
|
Fukazawa K et al. |
[Antimicrobial resistance testing of H. pylori epsilometer test and disk diffusion test]. |
1999 |
Nippon Rinsho |
pmid:10036939
|
Murakami K and Kimoto M |
[Antibiotic-resistant H. pylori strains in the last ten years in Japan]. |
1999 |
Nippon Rinsho |
pmid:10036940
|
Maeda S and Yoshida H |
[Detection of Helicobacter pylori 23S rRNA gene mutation associated with clarithromycin resistance and its clinical applicability]. |
1999 |
Nippon Rinsho |
pmid:10036941
|
Sekine H et al. |
[Recurrence rate of H. pylori after successful eradication and second eradication therapy after initial failure of treatment]. |
1999 |
Nippon Rinsho |
pmid:10036947
|
Iwasaki A |
[Eradication rate and side effect from a point of view of Helicobacter pylori eradication of peptic ulcer disease in dual therapy or new triple therapy]. |
1999 |
Nippon Rinsho |
pmid:10036949
|
Habu Y et al. |
[Evaluation of the efficacy and the cost-effectiveness of proton pump inhibitor-based dual and triple therapy regimens for H. pylori eradication in peptic ulcer disease]. |
1999 |
Nippon Rinsho |
pmid:10036950
|
Shirai T et al. |
[Four kinds of new triple therapy regiments for Helicobacter pylori eradication in patients with peptic ulcer]. |
1999 |
Nippon Rinsho |
pmid:10036951
|
Nakagawa M et al. |
[A comparative study; one week treatment versus two weeks treatment with lansoprazol, amoxycillin and clarythromycin for the eradication of Helicobacter pylori in patient with gastric and duodenal ulcer]. |
1999 |
Nippon Rinsho |
pmid:10036952
|
Kihira K et al. |
[Triple therapy regimens involving H2 blockaders for therapy of Helicobacter pylori infections]. |
1999 |
Nippon Rinsho |
pmid:10036953
|
Goto T et al. |
[Erosive duodenitis after eradication therapy for Helicobacter pylori]. |
1999 |
Nihon Shokakibyo Gakkai Zasshi |
pmid:10047687
|
Wang G et al. |
Multiplex sequence analysis demonstrates the competitive growth advantage of the A-to-G mutants of clarithromycin-resistant Helicobacter pylori. |
1999 |
Antimicrob. Agents Chemother. |
pmid:10049289
|
Woo PC et al. |
Clarithromycin attenuates the inflammatory response induced by surgical trauma in a guinea pig model. |
1999 |
Pharmacol. Res. |
pmid:10051377
|
Kistler A et al. |
Therapeutic dilemma: crescentic mesangiocapillary glomerulonephritis type 1 in a patient on antituberculous therapy with rifampicin. |
1999 |
Nephrol. Dial. Transplant. |
pmid:10052525
|
Yan JJ et al. |
Disseminated Mycobacterium genavense infection in a patient with acquired immunodeficiency syndrome: first case report in Taiwan. |
1999 |
J. Formos. Med. Assoc. |
pmid:10063276
|
Keto Y et al. |
Healing of Helicobacter pylori-induced gastric ulcers in Mongolian gerbils: combined treatment with omeprazole and clarithromycin. |
1999 |
Dig. Dis. Sci. |
pmid:10063909
|